MYRIAD GENETICS, INC. — Net Income by Fiscal Year
17 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/4cc5a09f-b8ba-4c93-8a99-d2613696cc3f/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-366.0M | 2025-01-01 – 2025-12-31 | evidence 0000899923-26-000031 |
| FY 2024 | $-127.0M | 2024-01-01 – 2024-12-31 | evidence 0000899923-26-000031 |
| FY 2023 | $-263.0M | 2023-01-01 – 2023-12-31 | evidence 0000899923-26-000031 |
| FY 2022 | $-112.0M | 2022-01-01 – 2022-12-31 | evidence 0000899923-23-000011 |
| FY 2021 | $-27.0M | 2021-01-01 – 2021-12-31 | evidence 0000899923-26-000031 |
| FY 2020 | $-223.6M | 2020-01-01 – 2020-12-31 | evidence 0000899923-22-000033 |
| FY 2019 | $4.6M | 2018-07-01 – 2019-06-30 | evidence 0001564590-19-031849 |
| FY 2018 | $133.3M | 2017-07-01 – 2018-06-30 | evidence 0001564590-19-031849 |
| FY 2017 | $17.4M | 2016-07-01 – 2017-06-30 | evidence 0001564590-19-031849 |
| FY 2016 | $117.2M | 2015-07-01 – 2016-06-30 | evidence 0001564590-18-022312 |
| FY 2015 | $79.8M | 2014-07-01 – 2015-06-30 | evidence 0001564590-18-022312 |
| FY 2014 | $176.2M | 2013-07-01 – 2014-06-30 | evidence 0001193125-15-287589 |
| FY 2013 | $147.2M | 2012-07-01 – 2013-06-30 | evidence 0001193125-15-287589 |
| FY 2012 | $112.2M | 2011-07-01 – 2012-06-30 | evidence 0001193125-12-356879 |
| FY 2011 | $100.7M | 2010-07-01 – 2011-06-30 | evidence 0001193125-11-223211 |
| FY 2010 | $152.3M | 2009-07-01 – 2010-06-30 | evidence 0001193125-11-223211 |
| FY 2009 | $84.6M | 2008-07-01 – 2009-06-30 | evidence 0001193125-11-223211 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
MYRIAD GENETICS, INC. — all facts · Revenue · Operating Income